Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications

P Reimer, G Schneider, W Schima - European radiology, 2004 - Springer
Hepatobiliary contrast agents with uptake into hepatocytes followed by variable biliary
excretion represent a unique class of cell-specific MR contrast agents. Two hepatobiliary …

Tissue-specific MR contrast agents

HJ Weinmann, W Ebert, B Misselwitz… - European journal of …, 2003 - Elsevier
The purpose of this review is to outline recent trends in contrast agent development for
magnetic resonance imaging. Up to now, small molecular weight gadolinium chelates are …

Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree

MK Seale, OA Catalano, S Saini, PF Hahn… - Radiographics, 2009 - pubs.rsna.org
Hepatobiliary-specific contrast agents are one of several classes of contrast agents
available for magnetic resonance (MR) imaging of the liver. These agents are taken up by …

Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride–filled microbubble contrast agent: diagnostic performance and …

E Quaia, F Calliada, M Bertolotto, S Rossi, L Garioni… - Radiology, 2004 - pubs.rsna.org
PURPOSE: To assess whether characterization of solid focal liver lesions could be improved
by using ultrasonographic (US) contrast-specific modes after sulfur hexafluoride–filled …

Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in …

R Hammerstingl, A Huppertz, J Breuer, T Balzer… - European …, 2008 - Springer
A multicenter study has been employed to evaluate the diagnostic efficacy of magnetic
resonance imaging (MRI) using the new liver-specific contrast agent gadoxetic acid (Gd …

Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid–enhanced MR images with intraoperative findings

A Huppertz, T Balzer, A Blakeborough, J Breuer… - Radiology, 2004 - pubs.rsna.org
PURPOSE: To evaluate the safety and efficacy of gadoxetic acid disodium–enhanced
magnetic resonance (MR) imaging for the detection of focal liver lesions, with results of …

Accurate Differentiation of Focal Nodular Hyperplasia from Hepatic Adenoma at Gadobenate Dimeglumine–enhanced MR Imaging: Prospective Study1

L Grazioli, G Morana, MA Kirchin, G Schneider - Radiology, 2005 - pubs.rsna.org
PURPOSE: To prospectively determine the accuracy of differentiating benign focal nodular
hyperplasia (FNH) from hepatic adenoma (HA) and liver adenomatosis (LA) by using …

Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance …

T Ichikawa, K Saito, N Yoshioka, A Tanimoto… - Investigative …, 2010 - journals.lww.com
Objectives: To prospectively evaluate the safety and efficacy of combined unenhanced and
gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance (MR) imaging …

MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA

CJ Zech, KA Herrmann, MF Reiser… - Magnetic resonance in …, 2007 - jstage.jst.go.jp
The appropriate staging of malignant tumors is increasingly important as new therapeutic
strategies develop. Because metastatic involvement of the liver in extrahepatic malignant …

[HTML][HTML] Characterization of focal liver lesions with SonoVue®-enhanced sonography: International multicenter-study in comparison to CT and MRI

H Trillaud, JM Bruel, PJ Valette, V Vilgrain… - World journal of …, 2009 - ncbi.nlm.nih.gov
AIM: To evaluate in a multicenter study whether the sonographic characterization of focal
liver lesions can be improved using SonoVue®-enhancement; and to compare this method …